Search For "in africa for africa strategy"
Strides Pharma reports Q2 EBITDA at Rs 150 crore on revenue of Rs 718 cror
Updated : 6 years, 7 months ago IST
Bengaluru (Karnataka) [India], Oct 25 (ANI): Strides Pharma Science on Friday reported consolidated revenues at Rs 718 crore during the July to September quarter, demonstrating a 37 per cent year-on-year growth.
Read More